FDA approves COVID-19 treatment after successful use of STEM CELLS from RESTEM

CORONA, Calif., and MIAMI and SIOUX FALLS, S.D., May 14, 2020 — RESTEM, a leading cell-based therapeutics company, announced today it has received approval from the U.S. Food and Drug Administration (FDA) for a 60-patient Phase I/IIa study using umbilical cord mesenchymal stem cells to treat patients with severe cases of COVID-19. The study will be the first of its kind in the U.S.  “We are […]

Patient Credits Stem Cell Treatment With Saving Her Life

MIAMI (CBSMiami) – The U.S. Food and Drug Administration gave Baptist Health approval to test a stem cell treatment on COVID-19 patients and so far it’s come back with positive results.  The treatment has proven successful with three patients.  One of those patients, Ruth Ramirez says it saved her life. Ramirez was discharged from the hospital on Friday afternoon.  […]

COVID-19: Three Patients Successfully Treated with RESTEM Stem Cells

RESTEM, a leading-edge biotechnology company, and Baptist Health South Florida, today announced three COVID-19 patients with acute respiratory distress syndrome (ARDS) are the first to successfully be treated in the U.S. with umbilical cord mesenchymal stem cells under an emergency approval from the Food and Drug Administration (FDA). Baptist Health physicians, Guenther Koehne, M.D., Ph.D., and Javier […]

3 Miami COVID-19 Patients Successfully Recovered with Stem Cell Therapy

 A team of South Florida doctors have successfully treated three critically ill COVID-19 patients with an experimental stem cell treatment for the first time, signaling a potential path to recovery for patients experiencing acute respiratory failure.  The doctors at Baptist Health South Florida, say the intravenous treatment is a “game-changer” and could pave the way for an […]